Page 2 - Baseline Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Regulatory submissions on track for govorestat (AT-007) for the treatment of Classic Galactosemia to US FDA and EMA in 4Q 2023Two Upcoming Phase 3...

Regulatory progress for govorestat for the treatment of Classic Galactosemia, with potential NDA submission based on discussions with the FDA as well as EMA Marketing Authorization Application... -Today at 07:04 am- MarketScreener

The ongoing ARISE-HF Phase 3 global clinical trial is evaluating the safety and efficacy of AT-001 (caficrestat) in improving or preventing worsening of cardiac functional capacity in Diabetic Cardiomyopathy (DbCM); topline data from the study is expected...

Stockholders, especially their executives, that's how they give them such extravagant pay. they were about to announce, they announced that the day before. the derailment. so, we are holding them accountable. that is my biggest job. but also, what do you do with the second generation, and the third generation. so, that is why i am there for the long haul. >> i was interested, today to see a letter that you cosigned today with the junior senator from ohio, republican j.d. vance. now you incentives and obviously come from different parts of the ideological number line and your very different men...

Department of Chemicals and Petrochemicals was established under the Ministry of Chemicals and Fertilizers in 1991 and is responsible for the policy, planning, development and regulation of Chemicals and Petrochemicals Industries